NO20076187L - Fast, transdermalt, terapeutisk system omfattende UV-absorber - Google Patents

Fast, transdermalt, terapeutisk system omfattende UV-absorber

Info

Publication number
NO20076187L
NO20076187L NO20076187A NO20076187A NO20076187L NO 20076187 L NO20076187 L NO 20076187L NO 20076187 A NO20076187 A NO 20076187A NO 20076187 A NO20076187 A NO 20076187A NO 20076187 L NO20076187 L NO 20076187L
Authority
NO
Norway
Prior art keywords
absorber
therapeutic system
layer
transdermal therapeutic
tts
Prior art date
Application number
NO20076187A
Other languages
English (en)
Norwegian (no)
Inventor
Thomas Langguth
Stefan Bracht
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20076187L publication Critical patent/NO20076187L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20076187A 2005-05-02 2007-11-30 Fast, transdermalt, terapeutisk system omfattende UV-absorber NO20076187L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05009579A EP1719504A1 (de) 2005-05-02 2005-05-02 Festes transdermales therapeutisches System mit UV-Absorber
PCT/EP2006/003959 WO2006117139A2 (de) 2005-05-02 2006-04-28 Festes transdermales therapeutisches system mit uv-absorber

Publications (1)

Publication Number Publication Date
NO20076187L true NO20076187L (no) 2007-11-30

Family

ID=34981458

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076187A NO20076187L (no) 2005-05-02 2007-11-30 Fast, transdermalt, terapeutisk system omfattende UV-absorber

Country Status (26)

Country Link
EP (2) EP1719504A1 (es)
JP (2) JP5360877B2 (es)
KR (2) KR101351161B1 (es)
CN (2) CN101171001A (es)
AR (1) AR055927A1 (es)
AU (1) AU2006243442A1 (es)
BR (1) BRPI0611087A2 (es)
CA (1) CA2605112C (es)
CR (1) CR9483A (es)
CY (1) CY1115757T1 (es)
DK (1) DK1879560T3 (es)
DO (1) DOP2006000100A (es)
EA (1) EA200702344A1 (es)
ES (1) ES2523663T3 (es)
GT (1) GT200600183A (es)
IL (1) IL186945A0 (es)
MX (1) MX2007013779A (es)
NO (1) NO20076187L (es)
PE (1) PE20061414A1 (es)
PL (1) PL1879560T3 (es)
PT (1) PT1879560E (es)
SI (1) SI1879560T1 (es)
TW (1) TW200719902A (es)
UY (1) UY29511A1 (es)
WO (1) WO2006117139A2 (es)
ZA (1) ZA200710418B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2515918C (en) 2003-02-21 2010-11-16 Schering Ag Uv stable transdermal therapeutic plaster
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
WO2012031999A2 (en) * 2010-09-06 2012-03-15 Bayer Pharma Aktiengesellschaft Low-dose transdermal patches with high drug release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
DE59107052D1 (de) * 1990-03-30 1996-01-25 Ciba Geigy Ag Lackzusammensetzungen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
US7384650B2 (en) * 1999-11-24 2008-06-10 Agile Therapeutics, Inc. Skin permeation enhancement composition for transdermal hormone delivery system
EP1269999B1 (en) * 2000-03-17 2013-05-01 Hisamitsu Pharmaceutical Co. Inc. Ultraviolet-shielding patch
CA2515918C (en) * 2003-02-21 2010-11-16 Schering Ag Uv stable transdermal therapeutic plaster
EP1452173A1 (de) * 2003-02-25 2004-09-01 Schering AG UV-stabiles transdermales Pflaster
BRPI0414249B1 (pt) * 2003-09-11 2013-08-06 dispersão polimérica aquosa concentrada, processo para a preparação da referida dispersão, pó de polímero, composição estabilizada e de revestimento em pó estabilizada, bem como uso da referida dispersão de polímero e do pó de polímero

Also Published As

Publication number Publication date
SI1879560T1 (sl) 2015-01-30
EP1879560A2 (de) 2008-01-23
DOP2006000100A (es) 2007-01-31
CA2605112A1 (en) 2006-11-09
DK1879560T3 (en) 2014-11-24
PE20061414A1 (es) 2007-01-26
AU2006243442A1 (en) 2006-11-09
IL186945A0 (en) 2008-02-09
KR101426218B1 (ko) 2014-08-05
JP5360877B2 (ja) 2013-12-04
PT1879560E (pt) 2014-11-19
MX2007013779A (es) 2008-01-22
PL1879560T3 (pl) 2015-02-27
CN101171001A (zh) 2008-04-30
EP1879560B1 (de) 2014-08-27
WO2006117139A3 (de) 2007-04-19
EP1719504A1 (de) 2006-11-08
JP2008540352A (ja) 2008-11-20
CN108969507A (zh) 2018-12-11
GT200600183A (es) 2007-01-03
CR9483A (es) 2008-01-21
ES2523663T3 (es) 2014-11-28
EA200702344A1 (ru) 2008-12-30
BRPI0611087A2 (pt) 2010-08-03
AR055927A1 (es) 2007-09-12
WO2006117139A2 (de) 2006-11-09
CA2605112C (en) 2013-11-05
KR20080003854A (ko) 2008-01-08
CY1115757T1 (el) 2017-01-25
JP2013177451A (ja) 2013-09-09
UY29511A1 (es) 2006-08-31
KR20130099203A (ko) 2013-09-05
KR101351161B1 (ko) 2014-01-14
ZA200710418B (en) 2009-08-26
TW200719902A (en) 2007-06-01

Similar Documents

Publication Publication Date Title
Yan et al. Dural afferents express acid-sensing ion channels: a role for decreased meningeal pH in migraine headache
Cheang et al. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice
Pereira et al. Memory impairment induced by sodium fluoride is associated with changes in brain monoamine levels
ES2599802T3 (es) Sistema de administración transdérmica
AR097045A2 (es) Sistema terapéutico transdérmico
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
BRPI0407615B8 (pt) sistema terapêutico transdérmico estável à radiação ultravioleta
Strupp et al. Pharmacotherapy of vestibular and cerebellar disorders and downbeat nystagmus: Translational and back‐translational research
NO20076187L (no) Fast, transdermalt, terapeutisk system omfattende UV-absorber
Trenkwalder et al. A placebo‐controlled trial of AQW051 in patients with moderate to severe levodopa‐induced dyskinesia
AU2021328741A1 (en) Pharmaceutical compositions and methods for treating Parkinson's disease
BRPI0507645A (pt) anticorpo, método de detectar um distúrbio ósseo metabólico, kit para detectar um distúrbio ósseo metabólico, composição farmacêutica para o tratamento de um distúrbio ósseo metabólico, e, método de triar uma substáncia efetiva para tratar e/ou prevenir um distúrbio ósseo metabólico
BR0212026A (pt) Sistema terapêutico transdérmico com fentanila ou substâncias análogas
Cruz et al. Stress-induced cross-sensitization to amphetamine is related to changes in the dopaminergic system
Park et al. Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells
Hadgraft et al. Passive transdermal drug delivery systems: recent considerations and advances
Walker et al. Cerebral and skeletal muscle feed artery vasoconstrictor responses in a mouse model with greater large elastic artery stiffness
CL2013000709A1 (es) Composicion que contiene nifurtimox y un antihelmintico seleccionado de: pf1022, emopdepsido, tribendimidina, amidantel, bay d 9216, praziquantel o benzoato de bencilo; util en el tratamiento de enfermedades causadas por giardias (div. sol. 1577-10).
Cilurzo et al. Formulation study of a patch containing propranolol by design of experiments
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
BR112012014107B8 (pt) sistema terapêutico transdérmico (tts) e processo de produção de tts
Sable et al. Antipsychotic treatment for late-life schizophrenia
WO2009007334A3 (de) Transdermale therapeutische systeme, welche den wirkstoff anastrozol enthalten
Müller Current and investigational non-dopaminergic agents for management of motor symptoms (including motor complications) in Parkinson’s disease
Mazzone et al. Topiramate in children with autistic spectrum disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application